Impact of Coronary Artery Disease on Outcomes in Patients Undergoing Percutaneous Edge-to-Edge Repair.

[1]  G. Nickenig,et al.  Percutaneous interventions for mitral and tricuspid heart valve diseases , 2019, Cardiovascular Intervention and Therapeutics.

[2]  A. Matta,et al.  Coronary artery disease is associated with valvular heart disease, but could it Be a predictive factor? , 2019, Indian heart journal.

[3]  M. Khan,et al.  Percutaneous Mitral Valve Repair versus Optimal Medical Therapy in Patients with Functional Mitral Regurgitation: A Systematic Review and Meta-Analysis , 2019, Journal of interventional cardiology.

[4]  G. Nickenig,et al.  Impact of coronary artery disease in patients undergoing transfemoral transcatheter aortic valve implantation. , 2017, International journal of cardiology.

[5]  M. Taramasso,et al.  SYNTAX score II in patients with coronary artery disease undergoing percutaneous mitral repair with the MitraClip. , 2017, International journal of cardiology.

[6]  G. Wang,et al.  Usefulness of the SYNTAX score II to predict 1-year outcome in patients with primary percutaneous coronary intervention , 2016, Coronary artery disease.

[7]  P. Boekstegers,et al.  One-year outcomes and predictors of mortality after MitraClip therapy in contemporary clinical practice: results from the German transcatheter mitral valve interventions registry , 2015, European heart journal.

[8]  Helmut Baumgartner,et al.  2014 ESC/EACTS Guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Developed with the special contribution of the European Association of Percutaneous , 2014, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery.

[9]  S. Blankenberg,et al.  Percutaneous mitral valve edge-to-edge repair: in-hospital results and 1-year follow-up of 628 patients of the 2011-2012 Pilot European Sentinel Registry. , 2014, Journal of the American College of Cardiology.

[10]  J. Hausleiter,et al.  Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. , 2013, Journal of the American College of Cardiology.

[11]  Antonio Colombo,et al.  Anatomical and clinical characteristics to guide decision making between coronary artery bypass surgery and percutaneous coronary intervention for individual patients: development and validation of SYNTAX score II , 2013, The Lancet.

[12]  P. Serruys,et al.  Quantification and impact of untreated coronary artery disease after percutaneous coronary intervention: the residual SYNTAX (Synergy Between PCI with Taxus and Cardiac Surgery) score. , 2012, Journal of the American College of Cardiology.

[13]  E. Foster,et al.  Acute and 12-month results with catheter-based mitral valve leaflet repair: the EVEREST II (Endovascular Valve Edge-to-Edge Repair) High Risk Study. , 2012, Journal of the American College of Cardiology.

[14]  Saibal Kar,et al.  Percutaneous repair or surgery for mitral regurgitation. , 2011, The New England journal of medicine.

[15]  Scott Lim,et al.  Percutaneous mitral repair with the MitraClip system: safety and midterm durability in the initial EVEREST (Endovascular Valve Edge-to-Edge REpair Study) cohort. , 2009, Journal of the American College of Cardiology.

[16]  P. Serruys,et al.  The SYNTAX Score: an angiographic tool grading the complexity of coronary artery disease. , 2005, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[17]  M. Enriquez-Sarano,et al.  Late outcome of mitral valve surgery for patients with coronary artery disease. , 2003, The Annals of thoracic surgery.

[18]  O. Alfieri,et al.  The double-orifice technique in mitral valve repair: a simple solution for complex problems. , 2001, The Journal of thoracic and cardiovascular surgery.